CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dong-E-E-Jiao Co Ltd Company Snapshot
Dong-E-E-Jiao Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dong-E-E-Jiao Co Ltd with three other companies in this sector in China: Livzon Pharmaceutical Group Incorporated (2017 sales of 8.53 billion Chinese Renmimbi [US$1.34 billion] of which 43% was Western Medicine), North China Pharmaceutical, Limited (7.71 billion Chinese Renmimbi [US$1.21 billion] of which 50% was Chemical Preparation Medicine), and Shanghai Shyndec Pharmaceutical Co Ltd (8.52 billion Chinese Renmimbi [US$1.34 billion] of which 60% was Drug Products).

Sales Analysis. Dong-E-E-Jiao Co Ltd reported sales of 7.37 billion Chinese Renmimbi (US$1.16 billion) for the year ending December of 2017. This represents an increase of 16.7% versus 2016, when the company's sales were 6.32 billion Chinese Renmimbi. This was the third consecutive year of growth at Dong-E-E-Jiao Co Ltd. Sales of Other Business saw an increase that was more than double the company's growth rate: sales were up 125.2% in 2017, from 12.18 million Chinese Renmimbi to 27.42 million Chinese Renmimbi. Dong-E-E-Jiao Co Ltd also saw significant increases in sales in Other (up 89.2% to 791.03 million Chinese Renmimbi) . Not all segments of Dong-E-E-Jiao Co Ltd experienced an increase in sales in 2017: sales of Medicine Trade fell 48.7% to 136.31 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Dong-E-E-Jiao Co Ltd
  Stock Performance Chart for Dong-E-E-Jiao Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): 56.44
(Figures in Chinese Renmimbi)
1 Week 1.0%   13 Weeks -4.5%  
4 Weeks -9.7%   52 Weeks -15.9%  
 
Dong-E-E-Jiao Co Ltd Key Data:
  Ticker: 000423 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 7,372,340,332
(Year Ending Jan 2018).
Employees: 4,817
  Currency: Chinese Renmimbi Market Cap: 36,912,975,548
  Fiscal Yr Ends: December Shares Outstanding: 654,021,537
  Share Type: A Gu Closely Held Shares: 205,769,205
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.